Randox Laboratories  

515 Industrial Boulevard
Kearneysville,  WV  22430

United States
  • Booth: 2509

Dedicated to Improving Health Worldwide For almost 40 years Randox have been at the forefront of diagnostics, leading the way with our disruptive technology and versatile product offering. With speed, accuracy and reliability at its core, our diverse product range comprises; third party quality control solutions, >100 diagnostic reagents including many niche & superior performance assays, clinical chemistry analysers, molecular diagnostic solutions for infectious diseases including COVID-19 and patented biochip technology. The revolutionary biochip is capable of simultaneously detecting hundreds of targets from a single patient sample. Complete patient profiling in this way facilitates faster patient testing, earlier diagnosis and improved patient pathways. Website: www.randox.com Email: Marketing@randox.com


  • Qnostics – Molecular Controls for Infectious Disease
    Qnostics has the most complete QC solution for molecular testing on the market. Designed to meet the demands of today’s molecular diagnostics laboratory and laboratories carrying out NAT, our range comprises hundreds of characterized viral, bacterial and fungal targets covering a wide range of diseases and infections....

  • Comprising hundreds of characterized viral, bacterial and fungal targets, the Qnostics range includes transplant associated diseases, respiratory diseases, blood borne viruses, sexually transmitted infections, gastrointestinal infections and central nervous system diseases.

    Our products can be used in the daily monitoring of assay performance, linearity assessment, assay evaluation, validation and verification of new assays and staff training.

    Qnostics controls are capable of monitoring the entire testing process including extraction, amplification and detection. As these controls are whole pathogen, they contain the full organism genome and where appropriate, Qnostics will provide multi-analyte controls designed for use with multiplex assays.

  • Acusera Anti-SARS-CoV-2 Controls
    The Acusera Anti-SARS-CoV-2 controls support assay validation and routine performance monitoring of serological assays for COVID-19. Conveniently supplied in a liquid format, this control has an unrivalled 30-day open vial stability therefore keeping waste to a minimum....

  • Supplied in a liquid ready-to-use format, this control requires no preparation. Manufactured using 100% human plasma, therefore providing a matrix similar to the patient sample, this control is true third party and ensures a completely unbiased assessment of performance.

    Both reactive and non-reactive controls are available and are suitable for use with anti-SARS-CoV-2 assays. This control is CE marked and has an unrivaled open-vial stability of 30-days at 2ºC to 8ºC.

    Find out more about the Acusera Anti-SARS-CoV-2 Control by visiting our website or emailing us at QualityControl@Randox.co

 Additional Info

Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?